pharmaphorum5d
Civica plans shake-up of insulin sector with low-cost biosimilars
Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.
The Associated Press on MSN24d
Newsom Committed California to Making Its Own Insulin. It’s at Least a Year Behind His Schedule
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind schedule ...
SFGate25d
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Civica, Inc., the nonprofit drug manufacturer contracted to produce insulin for California, has not started clinical trials or applied for approval from the federal Food and Drug Administration ...